PNUR125 Week 8 Simulation Lab Pre-Readings
TIA and CVA
o Lewis et al., (4thCanadian ed.) Chapter60, pg. 1507-1514
Dysphagia
o Lewis et al., (4thCanadian ed.) Chapter 13, E-Text pg.241 (Table 13-11 Section
‘Dysphagia’)
Fluid and Electrolyte Imbalances
o Lewis et al., (4thCanadian ed.) Chapter 19, E-Text pg. 361-362
o Lewis et al., (4thCanadian ed.) Chapter 19, E-Text pg. 361 Table 19-4
o Lewis et al., (4thCanadian ed.) Chapter 19, E-Text pg. 359-367
o Lewis et al., (4thCanadian ed.) Chapter 19, E-Text pg. 369-374
Clostridium difficile and Precautions
o Lewis et al., (4thCanadian ed.) Chapter 45, E-Text pg. 1058-1059
Focus Charting (Charting by Exception and DAR Format)
o Potter & Perry E-text page #241-242 OR Kozier et al. E-text page 465-468
Risk Assessment Tools
o Braden Scale
 Lewis et al., (4thCanadian ed.) Chapter 14, E-Text pg. 241 (Table 14-14)
Pharmacology
o Review the following medications using Lilley (pharmacology) E-text in preparation
for sim lab:
o Heparin
o Colace
o Prednisone
o Furosemide
o Warfarin
o Cephaclor
o Novolin Toronto
o Norvasc
o ASA
o Plavix
CNO Documentation Standard
o https://www.cno.org/globalassets/docs/prac/41001_documentation.pdf
CNO Medication Standard
o https://www.cno.org/globalassets/docs/prac/41007_medication.pdf